Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

4.120 +0.050 (+1.23%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

23 24 Next >

Prediction: Artificial Intelligence Will Lead to Higher Returns With Biotech Stocks ↗

August 13, 2024

Efficiency in core processes is set to increase substantially due to AI.

Via The Motley Fool

Topics Artificial Intelligence

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RXRX, GVP, OBDE, OBDC on Behalf of Shareholders

August 12, 2024

From Halper Sadeh LLC

Via GlobeNewswire

Prediction: Buying Biotech and Pharma Stocks During This Sell-Off Will Be a Smart Move ↗

August 12, 2024

There isn't much to suggest these businesses are actually vulnerable.

Via The Motley Fool

Is Recursion Pharmaceuticals a Buy Ahead of Its Merger With Exscientia? ↗

August 11, 2024

The leading company pioneering artificial intelligence (AI)-fueled drug discovery could get much bigger.

Via The Motley Fool

Topics Artificial Intelligence

Recursion updates L(earnings) call on August 8th to 8:30 am ET / 6:30 am MT

August 08, 2024

From Recursion Pharmaceuticals

Via GlobeNewswire

Recursion to Report Second Quarter 2024 Business Updates and Financial Results on August 8th

August 05, 2024

Company to host public L(earnings) call on August 8th at 5:00 pm ET / 3:00 pm MT

From Recursion Pharmaceuticals

Via GlobeNewswire

AI-Powered Drug Discovery Firm Exscientia To Merge With Nvidia-Partner Recursion Pharmaceuticals ↗

August 08, 2024

Exscientia merges with Recursion Pharmaceuticals in an all-stock deal. The new entity, named Recursion, will focus on industrializing drug discovery with advanced AI technologies, boasting $850 million...

Via Benzinga

Topics Artificial Intelligence

RXRX Stock Earnings: Recursion Pharmaceuticals Meets EPS, Beats Revenue for Q2 2024 ↗

August 08, 2024

RXRX stock results show that Recursion Pharmaceuticals met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Via InvestorPlace

CORRECTION - Recursion Provides Business Updates and Reports Second Quarter 2024 Financial Results

August 08, 2024

From Recursion Pharmaceuticals

Via GlobeNewswire

RXRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Recursion Pharmaceuticals, Inc. Is Fair to Shareholders

August 08, 2024

From Halper Sadeh LLC

Via Business Wire

Recursion and Exscientia Enter Definitive Agreement to Create a Global Technology-Enabled Drug Discovery Leader with End-to-End Capabilities

August 08, 2024

Operational complementarities expected to yield annual synergies of approximately $100 million

From Recursion Pharmaceuticals, Inc.

Via GlobeNewswire

Recursion Provides Business Updates and Reports Second Quarter 2024 Financial Results

August 08, 2024

From Recursion Pharmaceuticals

Via GlobeNewswire

Is Recursion Pharmaceuticals a Millionaire-Maker? ↗

August 06, 2024

It's likely to experience a lot of growth.

Via The Motley Fool

99.9% of Nvidia's $380 Million Investment Portfolio Has Been Put to Work in These 4 Artificial Intelligence (AI)-Inspired Stocks ↗

July 31, 2024

Artificial intelligence (AI) colossus Nvidia has stakes in five publicly traded companies -- four of which account for almost every cent of its AI-driven portfolio.

Via The Motley Fool

Topics Artificial Intelligence

AI-Focused Drug Discovery Stocks Portfolio Up 7% Last Week; Up 19% MTD ↗

July 30, 2024

The AI-powered drug discovery process is expected to grow by a CAGR of 30% by 2030.

Via Talk Markets

Down About 47% This Year: Is Recursion Pharmaceuticals a Buy on the Dip? ↗

July 27, 2024

There's a lot to like about the company using automation and artificial intelligence to improve the new drug-discovery process.

Via The Motley Fool

Topics Artificial Intelligence

25 Best Artificial Intelligence Stocks to Buy Right Now ↗

July 25, 2024

Artificial intelligence is revolutionizing industries across the board. These 25 companies span the spectrum, providing investors with a diversified basket of AI-centric equities.

Via The Motley Fool

Topics Artificial Intelligence

These 7 AI Stocks Were Major Movers On Monday/Tuesday - Here's Why ↗

July 24, 2024

This article identifies the

Via Talk Markets

Topics Artificial Intelligence

3 Millionaire-Maker Artificial Intelligence (AI) Stocks ↗

July 18, 2024

For the next stage of the AI era, companies with purposeful, practical, and highly targeted solutions stand to benefit the most.

Via The Motley Fool

Topics Artificial Intelligence

Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD ↗

July 14, 2024

The 10 clinical-stage AI-focused and psychedelic compound-based drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio are UP 12.8% MTD after having gone DOWN 13.2%, on average,...

Via Talk Markets

Is Recursion Pharmaceuticals Stock a Buy? ↗

July 14, 2024

The company is ambitious and exploring exciting areas, but it's still early in the game.

Via The Motley Fool

1 Reason to Buy Recursion Pharmaceuticals Stock and 2 Reasons to Sell ↗

July 13, 2024

This biotech is on the verge of a groundbreaking innovation, but it might not get over the hump.

Via The Motley Fool

3 Healthcare Stocks Injecting AI for Big Gains ↗

July 13, 2024

Investors should keep a close eye on these AI healthcare stocks as they revolutionize the future of drug development and patient care.

Via InvestorPlace

Topics Artificial Intelligence

Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday ↗

July 12, 2024

Via Benzinga

These Nvidia-Backed Artificial Intelligence (AI) Stocks Could Soar 73% to 89% Higher, According to Wall Street ↗

July 12, 2024

Are the analysts right about these Nvidia-backed AI stocks?

Via The Motley Fool

Topics Artificial Intelligence

Nvidia Is Buying Shares of These 5 AI Companies. Should You Do the Same? ↗

July 10, 2024

SoundHound AI, Arm, Nano-X, Recursion, and TuSimple are all in Nvidia's portfolio.

Via The Motley Fool

Topics Artificial Intelligence

3 Longevity Stocks to Buy for Anti-Aging Breakthroughs ↗

July 08, 2024

Longevity stocks are at the forefront of combating age-related illnesses with transformative AI-driven drug discovery.

Via InvestorPlace

Why SoundHound AI Stock Lost 22% Last Month ↗

July 08, 2024

Check out why SoundHound AI's stock dropped in June, despite a complete lack of negative news. Is this AI stock a great buy today?

Via The Motley Fool

Topics Artificial Intelligence

3 Stocks This Amazon-Backed AI Says Will Turn $1K into $1M by 2030 ↗

July 03, 2024

These high-risk, high-reward stocks have the potential to turn $1K into $1M by 2030, according to Amazon-backed AI Claude 3.5 Sonnet.

Via InvestorPlace

Topics Artificial Intelligence

Cathie Wood's Ark Invest Sells Tesla Shares Worth $14.5M Amid Rally Driven By Q2 Delivery Numbers, Picks Up Palantir Shares Again Today ↗

July 02, 2024

Via Benzinga

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.